Bipolar disorder is a recurrent, heterogeneous condition that often begins in adolescence and typically requires lifelong, multimodal management. Advances in evidence-based assessment (EBA) offer structured frameworks for prediction, prescription, and progress monitoring, and pharmacological and psychosocial interventions supported by recent reviews and the Canadian Network for Mood and Anxiety Treatments (CANMAT)/International Society for Bipolar Disorders (ISBD) guidelines provide effective options across phases of illness. Despite these advances, the impact of evidence-based approaches remains blunted in practice: Diagnosis is often delayed, pharmacotherapy is inconsistently prescribed or monitored, psychosocial interventions are underused, and relapse prevention strategies are rarely sustained. Therefore, the field must embed prediction, treatment, and monitoring within community treatment settings—primary care, schools, digital platforms, and family systems—where risk can be identified early, preventive strategies can be delivered, and long-term maintenance can be supported. Framing EBA as a dynamic, community-anchored cycle offers the best chance of translating evidence into improved outcomes, bridging the gap between research efficacy and real-world effectiveness in the care of bipolar disorder.
Hannah Wolfson (Fri,) studied this question.